abstract |
There is provided a compound which is (a) a pyrimidine sulfonamide of formula (I) or (b) a pharmaceutically acceptable salt thereof, crystalline forms of the compound, processes for obtaining the compound, pharmaceutical intermediates used in the manufacture of the compound, and pharmaceutical compositions containing the compound. n n n n n n n n n n The compound is useful in the treatment of a disease/condition in which modulation of chemokine receptor activity is beneficial. |